Description
CARTALAX 20MG
20mg | Laboratory Research Grade
Strictly for Research Purposes – Not for Human Consumption
Cartalax 20mg is a short synthetic peptide bioregulator belonging to the cytogen group, specifically designed to target connective tissue and cartilage. Within experimental protocols, this molecule is studied for its potential to stimulate cartilage regeneration and improve the functional state of the musculoskeletal system by modulating collagen synthesis and metabolic processes within chondrocytes. Explore our full range of Research Peptides.
Product Technical Specifications
| Feature | Specification |
|---|---|
| Compound | Cartalax 20mg |
| Sequence | Ala-Glu-Asp |
| Molecular Formula | C12H19N3O8 |
| Molecular Weight | 333.3 g/mol |
| Analytical Purity | > 98% (HPLC Certified) |
| Format | Lyophilized Powder (Vacuum Stabilized) |
| Quantity | 20 mg per vial |
| Storage | -20°C (Dry) / 2–8°C (Reconstituted) |
| Grade | Laboratory Research Grade |
Research Application Areas
- Cartilage Tissue Support: Investigation into the repair and maintenance of cartilage structures in synovial joints.
- Spine and Joint Research: Study of the peptide’s impact on osteochondrosis and degenerative joint conditions.
- Collagen Synthesis: Analysis of metabolic pathways involving the production of structural proteins in connective tissues.
- Musculoskeletal Recovery: Research regarding the acceleration of recovery in cartilage following trauma or intensive physical stress.
⚠️ MANDATORY LEGAL DISCLAIMER: THIS PRODUCT IS NOT INTENDED FOR HUMAN CONSUMPTION. IT IS SOLD EXCLUSIVELY FOR LABORATORY USE AND RESEARCH PURPOSES.
